amoxicillin mip pharma 1000 mg tabletti
mip pharma gmbh - amoxicillin trihydrate - tabletti - 1000 mg - amoksisilliini
tolvon 10 mg tabletti, kalvopäällysteinen
n.v. organon - mianserin hydrochloride - tabletti, kalvopäällysteinen - 10 mg - mianseriini
tolvon 30 mg tabletti, kalvopäällysteinen
n.v. organon - mianserin hydrochloride - tabletti, kalvopäällysteinen - 30 mg - mianseriini
tolvon 60 mg tabletti, kalvopäällysteinen
n.v. organon - mianserin hydrochloride - tabletti, kalvopäällysteinen - 60 mg - mianseriini
reblozyl
bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - muut anemialääkkeet - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.
olanzapin abz-pharma 2.5 mg tabletti
ratiopharm gmbh - olanzapinum - tabletti - 2.5 mg - olantsapiini
olanzapin abz-pharma 5 mg tabletti
ratiopharm gmbh - olanzapinum - tabletti - 5 mg - olantsapiini
olanzapin abz-pharma 7.5 mg tabletti
ratiopharm gmbh - olanzapinum - tabletti - 7.5 mg - olantsapiini
olanzapin abz-pharma 10 mg tabletti
ratiopharm gmbh - olanzapinum - tabletti - 10 mg - olantsapiini
olanzapin abz-pharma 15 mg tabletti
ratiopharm gmbh - olanzapinum - tabletti - 15 mg - olantsapiini